Cohort studies on cancer and other diseases have agreed with the hypothesis of McMillan and Proctor, the doctors who first validated mGPS and suggested that raising the CRP level by >3 mg/L would achieve better predictive value [38,42,43,44]. Here, CRP is linked to cancer.